Abboxia – a Swedish innovative pharmaceutical company within specialty pharma

Abboxia is a Swedish privately owned pharmaceutical company with a focus on the Nordic region. We strive to provide medicines that are needed by the healthcare systems in the Nordic countries. We do this through the development, registration and marketing of medicines that the healthcare system needs.

Our business is based on long experience of the Nordic pharmaceutical market and on close cooperation with the healthcare system.

We cooperate with pharmaceutical manufacturers around Europe, all approved by European pharmaceutical authorities. Manufacturing takes place in accordance with current European pharmaceutical and environmental legislation. To ensure high delivery reliability, we stock and distribute our medicines via the leading distributors of medicines in the Nordics.

News 

August 2024

FrostPharma and Abboxia join forces under the FrostPharma name, becoming one of the Specialty Pharma companies with the broadest range of hospital products in the Nordic region.

The combination of FrostPharma’s strategic partnership and commercial track record with Abboxia’s portfolio development capabilities creates opportunities to deliver significantly more hospital pharmaceuticals to Nordic healthcare providers intended for use in patients with critical conditions.

By joining forces with Abboxia, FrostPharma has become one of the leading Specialty Pharma companies in the Nordics.

————————————————–

About FrostPharma and Abboxia

FrostPharma was founded end 2016 and has a strong track-record of building strategic partnerships with other pharmaceutical companies and to effectively commercialize a wide range of specialty pharma products across the Nordic markets.

Abboxia was founded in 2017 and has a strong track record of developing proprietary hospital products in the hospital segment for the Nordic market.